This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Jan A. Nolta is an American scientist and the director of the stem cell program at the UC Davis School of Medicine and Institute for Regenerative Cures. She is Scientific Director for the UC Davis Good Manufacturing Practice and editor of the journal Stem Cells. Nolta is known for her work with stem cell-related regenerative medicine. Nolta's current research focuses on treatment of Huntington's disease using mesenchymal stem cells. She was elected a AAAS Fellow in 2013.[1]
Jan A. Nolta | |
|---|---|
 | |
| Alma mater | California State University Sacramento, University of Southern California |
| Awards | AAAS Fellow, Top 50 most influential global stem cell scientists |
| Scientific career | |
| Fields | Stem Cells |
Career
editNolta received a Bachelor of Science degree in Biology from California State University Sacramento in 1984, took master’s classes at UC Davis, and later earned a Ph.D. in molecular microbiology from the University of Southern California. She was an assistant professor at Keck School of Medicine before becoming an associate professor at Washington University School of Medicine in St. Louis. After serving as Scientific Director of the Cell Processing and Gene Therapy Good Manufacturing Practice facility at Washington University in St. Louis, Nolta joined University of California, Davis in 2006.[2]
While working towards her masters at UC Davis, Nolta was hired by Donald Kohn at the Children's Hospital Los Angeles and worked on gene therapy procedures.
Nolta now serves as the Director of the Stem Cell Program at the UC Davis School of Medicine, as well as the Director of the UC Davis Institute for Regenerative Cures, a facility supported by the California Institute for Regenerative Medicine (CIRM).[3][4]
Research
editNolta's research focuses on human stem cells and regenerative medicine therapies. Nolta's work focuses primarily on neurodegenerative diseases, especially therapeutics for Huntington's disease. She also studies Parkinson's disease, ALS, Liver disease, lysosomal storage diseases, and peripheral vascular disease.[3] Her lab uses genetically engineered mesenchymal stem cells from the bone marrow of healthy donors to transport enzymes and proteins to other cells.[4]
Achievements
editNolta has acted as editor and editorial board member on eight scientific journals, including Stem Cells. She has published numerous peer-reviewed scientific journals and book chapters, and served on review panels for the National Institutes of Health and other grant-funding agencies.[2]
Works
edit- (ed) Genetic Engineering of Mesenchymal Stem Cells Springer Netherlands, 2006. ISBN 978-1-4020-3935-5
References
edit- ^ "AAAS Members Elected as Fellows". AAAS. Retrieved November 19, 2014.
- ^ a b "Jan Nolta brief biography". Jan Nolta Lab in the UC Davis Medical Center Institute for Regenerative Cures - 2014. Archived from the original on February 13, 2015. Retrieved November 3, 2014.
- ^ a b "Jan Nolta". Sac State Magazine. Spring 2011. p. 9. Retrieved November 17, 2014.
- ^ a b "Researchers Achieve Important Step Toward Treatment of Huntington's Disease". UC Health. August 25, 2011. Archived from the original on September 21, 2017. Retrieved November 18, 2014.
External links
edit- Kevin McCormack, From bench to bedside: a Q&A with stem cell expert Jan Nolta, CIRM, California's Stem Cell Agency, July 19, 2019